86 related articles for article (PubMed ID: 28790146)
1. CYP1A1-Mediated Intramolecular Rearrangement of Aminoazepane in GDC-0339.
Takahashi RH; Wang X; Segraves NL; Wang J; Chang JH; Khojasteh SC; Ma S
Drug Metab Dispos; 2017 Oct; 45(10):1084-1092. PubMed ID: 28790146
[TBL] [Abstract][Full Text] [Related]
2. Human Cytochrome P450 1A1 Adapts Active Site for Atypical Nonplanar Substrate.
Bart AG; Takahashi RH; Wang X; Scott EE
Drug Metab Dispos; 2020 Feb; 48(2):86-92. PubMed ID: 31757797
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the Mechanisms of Formation for Two Unusual Cytochrome P450-Mediated Fused Ring Metabolites of GDC-0623, a MAPK/ERK Kinase Inhibitor.
Takahashi RH; Ma S; Robinson SJ; Yue Q; Choo EF; Khojasteh SC
Drug Metab Dispos; 2015 Dec; 43(12):1929-33. PubMed ID: 26438627
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.
Ju W; Yang S; Ansede JH; Stephens CE; Bridges AS; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE; Wang MZ
J Pharm Sci; 2014 Jan; 103(1):337-49. PubMed ID: 24186380
[TBL] [Abstract][Full Text] [Related]
5. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine δ-Oxidation and Rearrangement.
Li W; Zhao W; Liu X; Huang X; Lopez OD; Leet JE; Fancher RM; Nguyen V; Goodrich J; Easter J; Hong Y; Caceres-Cortes J; Chang SY; Ma L; Belema M; Hamann LG; Gao M; Zhu M; Shu YZ; Humphreys WG; Johnson BM
Drug Metab Dispos; 2016 Jun; 44(6):809-20. PubMed ID: 27029743
[TBL] [Abstract][Full Text] [Related]
7. A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834.
Sodhi JK; Wong S; Kirkpatrick DS; Liu L; Khojasteh SC; Hop CE; Barr JT; Jones JP; Halladay JS
Drug Metab Dispos; 2015 Jun; 43(6):908-15. PubMed ID: 25845827
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
9. Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: structure elucidation using electrochemistry, mass spectrometry, and NMR.
Johansson T; Jurva U; Grönberg G; Weidolf L; Masimirembwa C
Drug Metab Dispos; 2009 Mar; 37(3):571-9. PubMed ID: 19074972
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
Indra R; Moserova M; Sulc M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
[TBL] [Abstract][Full Text] [Related]
11. Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor.
Liu L; Halladay JS; Shin Y; Wong S; Coraggio M; La H; Baumgardner M; Le H; Gopaul S; Boggs J; Kuebler P; Davis JC; Liao XC; Lubach JW; Deese A; Sowell CG; Currie KS; Young WB; Khojasteh SC; Hop CE; Wong H
Drug Metab Dispos; 2011 Oct; 39(10):1840-9. PubMed ID: 21742900
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
Bourrié M; Meunier V; Berger Y; Fabre G
J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
[TBL] [Abstract][Full Text] [Related]
13. Novel Mechanism of Decyanation of GDC-0425 by Cytochrome P450.
Takahashi RH; Halladay JS; Siu M; Chen Y; Hop CE; Khojasteh SC; Ma S
Drug Metab Dispos; 2017 May; 45(5):430-440. PubMed ID: 28188299
[TBL] [Abstract][Full Text] [Related]
14. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
[TBL] [Abstract][Full Text] [Related]
15. Induction of CYP1A1 and CYP2E1 in rat liver by histamine: binding and kinetic studies.
Dávila-Borja VM; Belmont JA; Espinosa JJ; Moreno-Sánchez R; Albores A; Montero RD
Arch Toxicol; 2007 Oct; 81(10):697-709. PubMed ID: 17431589
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Cresteil T
J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
18. Novel Homodimer Metabolites of GDC-0994 via Cytochrome P450-Catalyzed Radical Coupling.
Takahashi RH; Grandner JM; Bobba S; Liu Y; Beroza P; Zhang D; Ma S
Drug Metab Dispos; 2020 Jun; 48(6):521-527. PubMed ID: 32234735
[TBL] [Abstract][Full Text] [Related]
19. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
